jeff lapointe,  —

Recent Posts

• Study: Little understanding impacts patient quality of life in Fabry
• How I’m working to mitigate the risk of stroke with Fabry disease
• Less frequent Elfabrio ERT regimen for Fabry up for EU approval
• Fabry gene therapy EXG110 granted FDA’s orphan drug status
• Molecular fingerprint shows potential to spot Fabry in either sex
• Long-term ERT normalizes Fabry inflammation, oxidative stress
• Boy with Fabry disease diagnosed with co-occurring blood disorder
• Teva’s Galafold generic for Fabry disease may be available in US
• Less frequent Elfabrio dosing for Fabry disease appears safe, effective
• Fabry disease can’t dampen the adventurous spirit of my kids